Cataracts are the leading cause of blindness worldwide, resulting in over 30 million surgeries each year. These cases are expected to double within the next 10 years. About 25% of all patients develop secondary cataracts or posterior capsule opacification (PCO) postsurgery. PCO is a vision impairment disorder that develops from myofibroblasts migration and contraction that deforms the capsule surrounding the lens. Currently, Nd:YAG laser therapy is used to treat PCO; however, laser is not available worldwide and adverse side effects may arise. Thus, there is a considerable unmet need for more efficacious and convenient preventive treatments for PCO. Our work focuses on engineering an innovative, prophylactic sustained release platform for DNA-based nanocarriers to further reduce the incidence of PCO.
Methods:
Novel, optically clear, self-assembled poly(d,l-lactic-co-glycolic acid)-b-poly(ethylene glycol) (PLGA-PEG) triblock copolymer hydrogels were used for the sustained release of the DNA-based nanocarriers (3DNA®) loaded with cytotoxic doxorubicin (DOX) and targeted with a monoclonal antibody called G8 (3DNA:DOX:G8), which is specific to cells responsible for PCO.
Results:
The 29 (w/v)% polymer hydrogels with the 3DNA nanocarriers presented over 80% of light transmittance, soft mechanical properties (<350 Pa), and sustained release for 1 month.
Conclusions:
In this work, we show for the first time that the hydrophobic PLGA-PEG-PLGA hydrogels can be used as platforms for sustained delivery of nucleic acid-based nanocarriers. This work demonstrates that polymeric formulations can be used for the extended delivery of ocular therapeutics and other macromolecules to treat a variety of ocular conditions.
Get full access to this article
View all access options for this article.
References
1.
AliM., and ByrneM.E.Challenges and solutiosn in topical ocular drug-delivery systems. Expert Rev. Clin. Pharmacol. 1:145–161, 2008.
2.
AgrahariV., MandalA., AgrahariV.Trinh, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv. Transl. Res., 6:735–754, 2016.
3.
HughesP.M., OlejnikO., Chang-LinJ.E., and WilsonC.G.Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57:2010–32, 2005.
4.
MannermaaE., VellonenK.S., and UrttiA.Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv. Drug Deliv. Rev. 58:1136–63, 2006.
5.
EbrahimS., PeymanG.A., and LeeP.J.Applications of liposomes in ophthalmology. Surv. Ophthalmol. 50:167–182, 2005.
6.
AmeeduzzafarA., AliJ., FazilM., et al.Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv. 23:710–726, 2016.
7.
TsaiC.-H., WangP.-Y., LinI.C., et al.Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int. J. Mol. Sci. 19:2830, 2018.
8.
BarbuE., VerestiucL., NevellT.G., and TsibouklisJ.Polymeric materials for ophthalmic drug delivery: trends and perspectives. J. Mater. Chem. 16:3439–3443, 2006.
9.
OsornoL.L., MaldonadoD.E., WhitenerR.J., et al.Amphiphilic PLGA-PEG-PLGA triblock copolymer nanogels varying in gelation temperature and modulus for the extended and controlled release of hyaluronic acid. J. Appl. Polym. Sci. 2019; n/a:48678.
10.
ZhangL., ShenW., LuanJ., YangD., et al.Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel. Acta Biomaterialia. 23:271–281, 2015.
11.
GaoY., SunY., RenF., and GaoS.PLGA–PEG–PLGA hydrogel for ocular drug delivery of dexamethasone acetate. Drug Dev. Ind. Pharm. 36:1131–1138, 2010.
12.
YangX., TrinhH.M., AgrahariV., et al.Nanoparticle-based topical ophthalmic gel formulation for sustained release of hydrocortisone butyrate. AAPS PharmSciTech. 17:294–306, 2016.
13.
FanW., WuX., DingB., et al.Degradable gene delivery systems based on Pluronics-modified low-molecular-weight polyethylenimine: preparation, characterization, intracellular trafficking, and cellular distribution. Int. J. Nanomed. 7:1127–1138, 2012.
14.
LungwitzU., BreunigM., BlunkT., and GopferichA.Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60:247–66, 2005.
15.
GerhartJ., WernerL., MamalisN., et al.Depletion of Myo/Nog cells in the lens mitigates posterior capsule opacification in rabbits. Investig. Ophthalmol. Vis. Sci. 60:1813–1823, 2019.
16.
GerhartJ., GreenbaumM., CastaL., et al.Antibody-conjugated, DNA-based nanocarriers intercalated with doxorubicin eliminate myofibroblasts in explants of human lens tissue. J. Pharmacol. Exp. Ther. 361:60–67, 2017.
17.
KriegA.M.CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709–60, 2002.
18.
NilsenT.W., GrayzelJ., and PrenskyW.Dendritic nucleic acid structures. J. Theor. Biol. 187:273–284, 1997.
19.
HuangY.-H., PengW., FuruuchiN., et al.Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth. Cancer Res. 76:1549, 2016.
20.
GerhartJ., BastB., NeelyC., et al.MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle. J. Cell Biol. 155:381–392, 2001.
21.
GerhartJ., BaytionM., DeLucaS., et al.DNA Dendrimers Localize Myod mRNA in Presomitic Tissues of the Chick Embryo. J. Cell Biol. 149:825, 2000.
22.
GerhartJ., ElderJ., NeelyC., et al.MyoD-positive epiblast cells regulate skeletal muscle differentiation in the embryo. J. Cell Biol. 175:283–292, 2006.
23.
StronyR., GerhartJ., TornambeD., et al.NeuroM and MyoD are expressed in separate subpopulations of cells in the pregastrulating epiblast. Gene Expr. Patterns. 5:387–395, 2005.
24.
MoraJ.R., and GettsR.C.High-sensitivity detection methods for low-abundance RNA species: applications for functional genomics research. Expert Rev. Mol. Diagn. 7:775–785, 2007.
25.
GerhartJ., WithersC., GerhartC., et al.Myo/Nog cells are present in the ciliary processes, on the zonule of Zinn and posterior capsule of the lens following cataract surgery. Exp. Eye Res. 171:101–105, 2018.
26.
FiroozanM.S., PorkhialS., and NejadA.S.Effect of tissue and atmosphere's parameters on human eye temperature distribution. J. Thermal Biol. 47:51–58, 2015.
27.
KirchhofS., GoepferichA.M., and BrandlF.P.Hydrogels in ophthalmic applications. Eur. J. Pharm. Biopharm. 95:227–238, 2015.
28.
SakanishiY., AwanoM., MizotaA., et al.Age-related changes in spectral transmittance of the human crystalline Lens in situ. Ophthalmologica. 228:174–180, 2012.
29.
HeysK.R., CramS.L., and TruscottR.J.Massive increase in the stiffness of the human lens nucleus with age: the basis for presbyopia?. Mol. Vis. 10:956–63, 2004.
30.
WeeberH.A., EckertG., SoergelF., et al.Dynamic mechanical properties of human lenses. Exp Eye Res. 80:425–434, 2005.
31.
WangJ., JiangM., NilsenT.W., and GettsR.C.Dendritic nucleic acid probes for DNA biosensors. J. Am. Chem. Soc. 120:8281–8282, 1998.
32.
QiaoM., ChenD., MaX., et al.Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int. J. Pharm. 294:103–112, 2005.
33.
KhorshidN.K., ZhuK., KnudsenK.D., et al.Novel structural changes during temperature-induced self-assembling and gelation of PLGA-PEG-PLGA triblock copolymer in aqueous solutions. Macromol. Biosci. 16:1838–1852, 2016.
34.
HuynhC.T. and LeeD.S. Injectable temperature- and pH/temperature-sensitive block copolymer hydrogels. In: Polymeric and Self-Assembled Hydrogels from Fundamental Understanding to Applications. Xian JunLoh, OrenA. Scherman. United Kingdom: The Royal Society of Chemistry: 2012.
KhodaverdiE., KheirandishF., Mirzazadeh TekieF.S., et al.Preparation of a sustained release drug delivery system for dexamethasone by a thermosensitive, in situ forming hydrogel for use in differentiation of dental pulp. ISRN Pharm. 2013:983053–983053, 2013.
37.
YuL., ZhangZ., and DingJ.Influence of LA and GA Sequence in the PLGA block on the properties of thermogelling PLGA-PEG-PLGA block copolymers. Biomacromolecules. 12:1290–1297, 2011.
38.
TanodekaewS., GodwardJ., HeatleyF., et al.Gelation of aqueous solutions of diblock copolymers of ethylene oxide and D,L-lactide. Macromol. Chem. Phys. 198:3385–3395, 1997.
39.
JeongB., WindischC.F., ParkM.J., et al.Phase transition of the PLGA-g-PEG copolymer aqueous solutions. J. Phys. Chem. B. 107:10032–10039, 2003.
40.
YuL., ZhangH., and DingJ.A subtle end-group effect on macroscopic physical gelation of triblock copolymer aqueous solutions. Angew. Chem. Int. Ed. 45:2232–2235, 2006.
41.
GoelM., PiccianiR.G., LeeR.K., and BhattacharyaS.K.Aqueous humor dynamics: a review. Open Ophthalmol. J. 4:52–59, 2010.
42.
DanyshB.P., PatelT.P., CzymmekK.J., et al.Characterizing molecular diffusion in the lens capsule. Matrix Biol. 29:228–236, 2010.
43.
MayolL., BiondiM., QuagliaF., et al.Injectable thermally responsive mucoadhesive gel for sustained protein delivery. Biomacromolecules. 12:28–33, 2011.
44.
NishiyamaK., KinoshitaM., HaradaT., and KatsumotoY.Synthesis of optically clear molecular organogels using phenol and a sulfosuccinic surfactant in various solvents with cyclic geometries. J. Mol. Liquids. 268:685–690, 2018.
JeongJ.H., KimS.W., and ParkT.G.Biodegradable triblock copolymer of PLGA-PEG-PLGA enhances gene transfection efficiency. Pharm. Res. 21:50–4, 2004.
47.
SarkarS., ChoudhuryP., DindaS., and DasP.K.Tailor-made self-assemblies from functionalized amphiphiles: diversity and applications. Langmuir. 34:10449–10468, 2018.
48.
YuL., ChangG., ZhangH., and DingJ.Temperature-induced spontaneous sol–gel transitions of poly(D,L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(D,L-lactic acid-co-glycolic acid) triblock copolymers and their end-capped derivatives in water. J. Polym. Sci. Part A Polym. Chem. 45:1122–1133, 2007.
49.
LindmanB., MedronhoB., and KarlströmG.Clouding of nonionic surfactants. Curr. Opin. Colloid Interf. Sci. 22:23–29, 2016.
50.
ChangC.-W., ChoiD., KimW.J., et al.Non-ionic amphiphilic biodegradable PEG–PLGA–PEG copolymer enhances gene delivery efficiency in rat skeletal muscle. J. Control. Release. 118:245–253, 2007.
51.
BraemA.D., Campos-TeránJ., and LindmanB.Influence of DNA adsorption and DNA/cationic surfactant coadsorption on the interaction forces between hydrophobic surfaces. Langmuir. 20:6407–6413, 2004.
52.
CárdenasM., SchillénK., PebalkD., et al.Interaction between DNA and charged colloids could be hydrophobically driven. Biomacromolecules. 6:832–837, 2005.
53.
PanditN.K., and KisakaJ.Loss of gelation ability of Pluronic® F127 in the presence of some salts. Int. J. Pharm. 145:129–136, 1996.
54.
OkurH.I., HladílkováJ., RembertK.B., ChoY., HeydaJ., DzubiellaJ., CremerP.S., and JungwirthP.Beyond the hofmeister series: ion-specific effects on proteins and their biological functions. J. Phys. Chem. B. 121:1997–2014, 2017.
55.
JeongB., BaeY.H., and KimS.W.Thermoreversible gelation of PEG−PLGA−PEG triblock copolymer aqueous solutions. Macromolecules. 32:7064–7069, 1999.
56.
LamberS.R.Childhood cataracts. In: LambertS.R., and LyonsC.J., eds. Taylor and Hoyt's Pediatric Ophthalmology and Strabismus. 5th ed. London, UK: Elsevier Inc.; 2017.
57.
GorniG., VelázquezJ.J., MosaJ., BaldaR., et al.Transparent glass-ceramics produced by sol-gel: a suitable alternative for photonic materials. Materials (Basel, Switzerland). 11:212, 2018.
58.
AramakiK., KoitaniS., TakimotoE., et al.Hydrogelation with a water-insoluble organogelator–surfactant mediated gelation (SMG). Soft Matter. 15:8896–8904, 2019.
59.
HouY., FeiR., BurkesJ.C., et al.Thermoresponsive nanocomposite hydrogels: transparency, rapid deswelling and cell release. J. Biomater. Tissue Eng. 1, 2011:10.1166/jbt.2011.1005.
60.
CaoY., WangB., YangL., et al.In Vitro evaluation and dissipative particle dynamics simulation of PLGA-PEG-PLGA. J. Appl. Polym. Sci. 132, 2015.
61.
LombardoD., KiselevM.A., et al.Amphiphiles self-assembly: basic concepts and future perspectives of supramolecular approaches. Adv. Cond. Matter Phys. 2015:22, 2015.
62.
KongL.B., HuangY., QueW., et al.Introduction. In: KongL.B., HuangY.Z., QueW.X., ZhangT.S., LiS., ZhangJ., DongZ.L., and TangD.Y., eds. Transparent Ceramics. Cham: Springer International Publishing: 2015; p. 1–28.
63.
KongL.B., HuangY., QueW., et al.Grain growth and microstructure development. In: KongL.B., HuangY.Z., QueW.X., ZhangT.S., LiS., ZhangJ., DongZ.L., and TangD.Y., eds. Transparent Ceramics. Cham: Springer International Publishing; 2015; p. 519–579.
64.
KabanovA.V., BatrakovaE.V., and AlakhovV.Y.Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release. 82:189–212, 2002.
65.
QuickD.J., and AnsethK.S.DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality. J. Controll. Release. 96:341–351, 2004.
66.
DannertC., StokkeB.T., and DiasR.S.Nanoparticle-hydrogel composites: from molecular interactions to macroscopic behavior. Polymers. 11:275, 2019.
67.
GaoY., RenF., DingB., et al.A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel. J. Drug Target. 19:516–527, 2011.
68.
WangJ.Delivery of siRNA with nanoparticles based on PEG–PLA block polymer for cancer therapy. Nanomed. Nanotechnol. Biol. Med. 12:464, 2016.
69.
FredenbergS., WahlgrenM., ReslowM., et al.The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—a review. Int. J. Pharm. 415:34–52, 2011.
70.
LiawJ., ChangS.F., and HsiaoF.C.In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles. Gene Ther. 8:999–1004, 2001.
71.
YangF., TevesS.S., KempC.J., and HenikoffS.Doxorubicin, DNA torsion, and chromatin dynamics. Biochim. Biophys. Acta. 1845:84–89, 2014.
72.
AiroldiM., BaroneG., GennaroG., et al.Interaction of doxorubicin with polynucleotides. A Spectroscopic Study. Biochemistry., 53:2197–2207, 2014.
73.
ZustiakS.P., BoukariH., and LeachJ.B.Solute diffusion and interactions in cross-linked poly(ethylene glycol) hydrogels studied by Fluorescence Correlation Spectroscopy. Soft Matter. 6:3609–3618, 2010.
74.
LiJ., and MooneyD.J.Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1:16071, 2016.
75.
TaluS., SueirasV.M., MoyV.T., et al.Microphorlogy analysis of the anterior human lens capsule. Mol. Vis. 24:902–912, 2018.
76.
DanyshB.P., and DuncanM.K.The lens capsule. Exp. Eye Res. 88:151–164, 2009.
